Darifenacin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Darifenacin. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Diarrhea | 20.2% |
| Urogenital | 4.7% |
| Body as a whole | 2.7% |
| Nervous | 2.1% |
| Eye | 2.1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
ENABLEX® (darifenacin) extended-release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.
Source: FDA labeling via NIH DailyMed (set a293cece…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.